RNAC Earnings Cartesian Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.46 | 2026-04-30 | 10-Q |
| FY 2025 | 2025-12-31 | -5.02 | 2026-03-09 | 10-K |
| Q3 2025 | 2025-09-30 | -1.45 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.07 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.68 | 2026-04-30 | 10-Q |
| FY 2025 | 2024-12-31 | -4.49 | 2026-03-09 | 10-K |
| Q3 2025 | 2024-09-30 | -4.61 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -3.88 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -10.50 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -49.76 | 2025-03-13 | 10-K |
| Q3 2024 | 2023-09-30 | -8.20 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -6.46 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -4.24 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | 0.10 | 2024-03-07 | 10-K |
| Q3 2023 | 2022-09-30 | 0.15 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.17 | 2023-08-17 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.08 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | -0.22 | 2024-03-07 | 10-K |
| Q3 2022 | 2021-09-30 | -0.34 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.18 | 2022-08-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.